Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $330.6900 (1.89%) ($313.5310 - $330.8400) on Wed. Feb. 14, 2018. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.06% (three month average) | | RSI | 30 | | Latest Price | $330.6900(1.89%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | | Weekly Trend | REGN declines -6.4% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(61%) XLV(51%) IVW(44%) XBI(44%) IWF(43%) | | Factors Impacting REGN price | REGN will decline at least -1.03% in a week (0% probabilities).
UUP(-10%) VIXM(-8%) TLT(-7%) TIP(-1%) SHY(-1%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.03% (StdDev 2.06%) | | Hourly BBV | 0 () | | Intraday Trend | 2.9% | | | | | |
|
| Resistance Level | $355.53 | | 5 Day Moving Average | $331.39(-0.21%) | | 10 Day Moving Average | $335.31(-1.38%) | | 20 Day Moving Average | $355.53(-6.99%) | | To recent high | -16.2% | | To recent low | 2.5% | | Market Cap | $35.063b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |